hiprose35
About
Cost-utility investigation of second-line anti-diabetic therapy in patients together with diabetes type 2 symptoms mellitus badly governed on metformin.
Cost-utility investigation of second-line anti-diabetic therapy in patients together with diabetes type 2 symptoms mellitus badly governed on metformin.